Method for preventing hormone induced adverse effects

a technology of adverse effects and hormones, applied in the field of prevention of hormone induced adverse effects, can solve the problems of increasing the risk of osteoporosis and coronary heart disease, estrogens are positively correlated with an increased risk of endometrial cancer development, and diminishing the beneficial effects of estrogen on the plasma lipid profile, so as to prevent the adverse effects and increase the risk of developing cancer
US20010027216A1Inactive Publication Date: 2001-10-04LYCORED NATURAL PRODS INDS

Patent Information

Authority / Receiving Office
US ยท United States
Current Assignee / Owner
LYCORED NATURAL PRODS INDS
Publication Date
2001-10-04
Estimated Expiration
Not applicable ยท inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The present invention provides a method for preventing the adverse effects which may be associated with the administration of at least one hormone to a subject without detectable cancer comprising administering to such subject at least one carotenoid. The invention further provides a method for preventing a variety of adverse effects associated with the administration of hormones, including, for example, an increased risk for developing cancer. The invention further provides a method for preventing adverse effects without inhibiting the beneficial activity of the hormone. The invention further provides a method for preventing the adverse effects associated with administration of estrogen and / or progestin in hormone replacement therapy without inhibiting the beneficial activity of such hormone. The invention further provides a method for preventing the adverse effects associated with the administration of phytoestrogens. The invention further provides a method for preventing adverse effects associated with the administration of phytoestrogens without inhibiting the beneficial activity of such hormone.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] The present invention provides a method for preventing adverse effects associated with the administration of hormones such as phytoestrogens and steroidal estrogens.

[0002] Hormone intake by humans can occur through, inter alia, consumption of pharmaceutical compositions, foodstuffs, nutritional supplements, and nutraceuticals. Such hormones include phytoestrogens, or nonsteroidal estrogens, steroidal estrogens and progestins. Phytoestrogens comprise, for example, genistein, daidzein and glycitein, and their respective glucoside, malonylglucoside and acetylglucoside derivatives. Estrogens and progestins are known to be used for hormone replacement therapy (HRT) and in contraceptive medications. HRT with estrogens or with estrogen / progestin combinations has been the standard method for treating symptoms associated with menopause (Emster V L et al. (1988) Benefits and Risks of Menopausal Estrogen and / or Progestin Hormone Use, Prev. Med. 17:201-223). The onset of menopause in mat...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More